Active Ingredient Prescribing

active ingredient prescribing (aip) australia requires all medications are prescribed using active ingredients (the generic name in profile), except where specific criteria are met (item appears on the list of medicines for brand consideration (lmbc) or the list of excluded medicinal items (lemi)), or the prescriber specifies brand substitution not permitted in profile v8 7 and later, no preference settings are required to active aip; the rules are built into the prescribing workflow for more information on aip, please review https //www safetyandquality gov au/publications and resources/resource library/active ingredient prescribing user guide https //www safetyandquality gov au/publications and resources/resource library/active ingredient prescribing user guide note for clinics upgrading to profile v8 7 in may 2022, it is essential that the latest (version 2) may mims files are imported before using profile v8 7 the updated mims files include new information required for aip (such as active ingredient names, and medications on the lemi and lmbc lists which allow profile to best advise users while prescribing aip prescribing configuration profile has always supported the concept of aip (generic prescribing) and provides a preference to set generic prescribing by default by going to organisation/ preferences/scripts and instructions/interface tab and checking the prescribe generic by default checkbox checking this preference will reduce the number of aip challenge dialogs displayed whilst prescribing, as aip will become the prescriber’s default choice prescription options there are three options for prescribing aip name only this is the default for most prescriptions it is the equivalent of checking the generic checkbox and leaving the include brand name on script checkbox unchecked resulting printed script item aip name (brand name)where it is appropriate to include the brand on the prescription, check both the generic and the include brand name on script checkboxes resulting printed script item brand name onlywhere it is appropriate to prescribe by brand only, uncheck the generic checkbox and check the brand substitution not permitted checkbox resulting printed script item guidance during the prescribing process, aip guidance will assist the prescriber in selecting between aip, brand, or both prescribing by brand will ask the prescriber to select either aip only or aip including the brand name as well it is a national requirement that this challenge is presented whenever prescribing by brand if prescribing by brand is essential, the prescriber may press cancel and in the edit instruction window, check the brand substitution not permitted checkbox the list of medicines for brand consideration (lmbc) includes medicines prescribers should consider prescribing by brand as well as active ingredient, if clinically necessary for the treatment of their patient this list is maintained in profile automatically each time the monthly mims update is imported if a medication is on the lmbc and is prescribed generically (aip only), the following guidance will be displayed if the medication was originally selected as a generic, pressing yes will return the prescriber to the selection window to specifically choose a brand if the medication has been selected by brand, the dialog will close without further action, and the brand will be appended to the prescription name the list of excluded medicinal items (lemi) includes medicines which should be prescribed by brand only for practical and safety purposes this list is maintained in profile automatically each time the monthly mims updated is imported if a medication is on the lemi and is prescribed generically (aip only), the following guidance will be displayed if the medication was originally selected as a generic, pressing yes will return the prescriber to the selection window to specifically choose a brand if the medication has been selected by brand, the dialog will close without further action, and the brand will be appended to the prescription name